Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

6:35 PM ET Form 4
Insider Selling CrowdStrike Holdings, Inc. CRWD

CrowdStrike Holdings President and CEO George Kurtz Sells $5.31M of Stock

George Kurtz, President and CEO, sold 20,000 shares of CrowdStrike Holdings, Inc. at $261.16 to $268.81 a share (average $265.46) in 15 transactions, worth $5.31M in total between Sep 30, 2026 and Oct 1, 2026. Shares held after the trade: 7,560,261 (-0.0%).

Value
$5.31M
Shares
20,000
Average price
$265.46
Role
President and CEO
Holding change
-0.0%
Trade date
Sep 30, 2026 to Oct 1, 2026
6:34 PM ET Form 4
Insider Selling TransUnion TRU

TransUnion President, International Todd C. Skinner Sells $62.3K of Stock

Todd C. Skinner, President, International, sold 1,000 shares of TransUnion at $62.29 a share, worth $62.3K in total on Oct 1, 2026. Shares held after the trade: 54,764 (-1.8%).

Value
$62.3K
Shares
1,000
Price
$62.29
Role
President, International
Holding change
-1.8%
Trade date
Oct 1, 2026
6:33 PM ET Form 4
Insider Selling TransUnion TRU

TransUnion EVP, Chief Global Solutions Mohamed Abdelsadek Sells $15.6K of Stock

Mohamed Abdelsadek, EVP, Chief Global Solutions, sold 250 shares of TransUnion at $62.29 a share, worth $15.6K in total on Oct 1, 2026. Shares held after the trade: 53,181 (-0.5%).

Value
$15.6K
Shares
250
Price
$62.29
Role
EVP, Chief Global Solutions
Holding change
-0.5%
Trade date
Oct 1, 2026
6:22 PM ET Form 4
Insider Selling Alkermes plc. ALKS

Alkermes EVP, CLO, Alkermes, Inc. David Joseph Gaffin Sells $83.5K of Stock

David Joseph Gaffin, EVP, CLO, Alkermes, Inc., sold 2,034 shares of Alkermes plc. at $41.03 a share, worth $83.5K in total on Oct 2, 2026. Shares held after the trade: 221,388 (-0.9%).

Value
$83.5K
Shares
2,034
Price
$41.03
Role
EVP, CLO, Alkermes, Inc.
Holding change
-0.9%
Trade date
Oct 2, 2026
6:11 PM ET Form 4
Insider Selling AvePoint, Inc. AVPT

AvePoint CLO Brian Michael Brown Sells $141K of Stock

Brian Michael Brown, CLO, sold 10,000 shares of AvePoint, Inc. at $14.11 a share, worth $141K in total on Sep 30, 2026. Shares held after the trade: 364,604 (-2.7%).

Value
$141K
Shares
10,000
Price
$14.11
Role
CLO
Holding change
-2.7%
Trade date
Sep 30, 2026
6:10 PM ET Form 4
Insider Selling Planet Labs PBC PL

Planet Labs PBC Director Ita M. Brennan Sells $187K of Stock

Ita M. Brennan, Director, sold 11,500 shares of Planet Labs PBC at $16.30 a share, worth $187K in total on Oct 1, 2026. Shares held after the trade: 250,373 (-4.4%).

Value
$187K
Shares
11,500
Price
$16.30
Role
Director
Holding change
-4.4%
Trade date
Oct 1, 2026
6:06 PM ET Form 4
Insider Selling Alphabet Inc. GOOGL

Alphabet Director Frances Arnold Sells $28.3K of Stock

Frances Arnold, Director, sold 83 shares of Alphabet Inc. at $340.45 a share, worth $28.3K in total on Sep 30, 2026. Shares held after the trade: 19,076 (-0.4%).

Value
$28.3K
Shares
83
Price
$340.45
Role
Director
Holding change
-0.4%
Trade date
Sep 30, 2026
6:03 PM ET Form 4
Insider Selling PennyMac Mortgage Investment Trust PMT

PennyMac Mortgage Investment Trust CAO Gregory L. Hendry Sells $19.2K of Stock

Gregory L. Hendry, CAO, sold 2,444 shares of PennyMac Mortgage Investment Trust at $7.86 a share, worth $19.2K in total on Oct 1, 2026. Shares held after the trade: 4,886 (-33.3%).

Value
$19.2K
Shares
2,444
Price
$7.86
Role
CAO
Holding change
-33.3%
Trade date
Oct 1, 2026
5:55 PM ET Form 4
Insider Selling Roblox Corp RBLX

Roblox Insider Gregory Baszucki Sells $714K of Stock

Gregory Baszucki sold 16,666 shares of Roblox Corp at $42.57 to $43.03 a share (average $42.87) in 4 transactions, worth $714K in total on Oct 1, 2026. Shares held after the trade: 1,252,836 (-0.4%).

Value
$714K
Shares
16,666
Average price
$42.87
Holding change
-0.4%
Trade date
Oct 1, 2026
5:53 PM ET Form 4
Insider Selling Mineralys Therapeutics, Inc. MLYS

Mineralys Therapeutics CEO Jon Congleton Sells $1.91M of Stock

Jon Congleton, CEO, sold 75,000 shares of Mineralys Therapeutics, Inc. at $25.46 a share, worth $1.91M in total on Sep 30, 2026. Shares held after the trade: 528,621 (-12.4%).

Value
$1.91M
Shares
75,000
Price
$25.46
Role
CEO
Holding change
-12.4%
Trade date
Sep 30, 2026
5:51 PM ET Form 4
Insider Selling Rivian Automotive, Inc. RIVN

Rivian Automotive Chief Administrative Officer Michael John Callahan Sells $225K of Stock

Michael John Callahan, Chief Administrative Officer, sold 15,000 shares of Rivian Automotive, Inc. at $15.00 a share, worth $225K in total on Oct 1, 2026. Shares held after the trade: 1,001,776 (-1.5%).

Value
$225K
Shares
15,000
Price
$15.00
Role
Chief Administrative Officer
Holding change
-1.5%
Trade date
Oct 1, 2026
5:51 PM ET Form 4
Insider Selling Oric Pharmaceuticals, Inc. ORIC

Oric Pharmaceuticals Director Richard A. Heyman Sells $86.5K of Stock

Richard A. Heyman, Director, sold 6,700 shares of Oric Pharmaceuticals, Inc. at $12.91 a share, worth $86.5K in total on Oct 1, 2026. Shares held after the trade: 203,472 (-1.5%).

Value
$86.5K
Shares
6,700
Average price
$12.91
Role
Director
Holding change
-1.5%
Trade date
Oct 1, 2026
5:50 PM ET Form 4
Insider Selling Rubrik, Inc. RBRK

Rubrik Director John Wendell Thompson Sells $1.56M of Stock

John Wendell Thompson, Director, sold 13,500 shares of Rubrik, Inc. at $114.68 to $116.47 a share (average $115.69) in 6 transactions, worth $1.56M in total on Oct 1, 2026. Shares held after the trade: 8,362 (-22.3%).

Value
$1.56M
Shares
13,500
Average price
$115.69
Role
Director
Holding change
-22.3%
Trade date
Oct 1, 2026
5:50 PM ET Form 4
Insider Selling Cactus, Inc. WHD

Cactus Chairman and CEO Scott Bender Sells $6.2M of Stock

Scott Bender, Chairman and CEO, sold 100,000 shares of Cactus, Inc. at $61.97 a share, worth $6.2M in total on Oct 1, 2026. Shares held after the trade: 120,527 (-45.3%).

Value
$6.2M
Shares
100,000
Price
$61.97
Role
Chairman and CEO
Holding change
-45.3%
Trade date
Oct 1, 2026
5:50 PM ET Form 4
Insider Selling Cactus, Inc. WHD

Cactus President Joel Bender Sells $6.2M of Stock

Joel Bender, President, sold 100,000 shares of Cactus, Inc. at $61.97 a share, worth $6.2M in total on Oct 1, 2026. Shares held after the trade: 41,519 (-70.7%).

Value
$6.2M
Shares
100,000
Price
$61.97
Role
President
Holding change
-70.7%
Trade date
Oct 1, 2026
5:48 PM ET Form 4
Insider Selling First Solar, Inc. FSLR

First Solar CTO Markus Gloeckler Sells $139K of Stock

Markus Gloeckler, CTO, sold 800 shares of First Solar, Inc. at $174.00 a share, worth $139K in total on Oct 1, 2026. Shares held after the trade: 5,042 (-13.7%).

Value
$139K
Shares
800
Price
$174.00
Role
CTO
Holding change
-13.7%
Trade date
Oct 1, 2026
5:48 PM ET Form 4
Insider Selling Anaptysbio, Inc ANAB

Anaptysbio Director Hollings Renton Sells $249K of Stock

Hollings Renton, Director, sold 5,000 shares of Anaptysbio, Inc at $49.87 a share, worth $249K in total on Oct 1, 2026. Shares held after the trade: 10,995 (-31.3%).

Value
$249K
Shares
5,000
Price
$49.87
Role
Director
Holding change
-31.3%
Trade date
Oct 1, 2026
5:38 PM ET Form 4
Insider Selling Roivant Sciences Ltd. ROIV

Roivant Sciences President & Immunovant CEO Eric Venker Sells $7.32M of Stock

Eric Venker, President & Immunovant CEO, sold 200,000 shares of Roivant Sciences Ltd. at $36.62 a share, worth $7.32M in total on Sep 30, 2026. Shares held after the trade: 1,599,154 (-11.1%).

Value
$7.32M
Shares
200,000
Price
$36.62
Role
President & Immunovant CEO
Holding change
-11.1%
Trade date
Sep 30, 2026
5:37 PM ET Form 4
Insider Selling Stoke Therapeutics, Inc. STOK

Stoke Therapeutics General Counsel & Corp Sec Jonathan Allan Sells $16.5K of Stock

Jonathan Allan, General Counsel & Corp Sec, sold 627 shares of Stoke Therapeutics, Inc. at $26.33 a share, worth $16.5K in total on Oct 2, 2026. Shares held after the trade: 20,598 (-3.0%).

Value
$16.5K
Shares
627
Price
$26.33
Role
General Counsel & Corp Sec
Holding change
-3.0%
Trade date
Oct 2, 2026
5:36 PM ET Form 4
Insider Selling Stoke Therapeutics, Inc. STOK

Stoke Therapeutics CMO Barry Ticho Sells $27.5K of Stock

Barry Ticho, CMO, sold 1,051 shares of Stoke Therapeutics, Inc. at $26.16 a share, worth $27.5K in total on Oct 1, 2026. Shares held after the trade: 19,059 (-5.2%).

Value
$27.5K
Shares
1,051
Price
$26.16
Role
CMO
Holding change
-5.2%
Trade date
Oct 1, 2026
5:34 PM ET Form 4
Insider Selling Walmart Inc. WMT

Walmart EVP Daniel J. Bartlett Sells $417K of Stock

Daniel J. Bartlett, EVP, sold 3,990 shares of Walmart Inc. at $104.41 a share, worth $417K in total on Oct 1, 2026. Shares held after the trade: 618,359 (-0.6%).

Value
$417K
Shares
3,990
Price
$104.41
Role
EVP
Holding change
-0.6%
Trade date
Oct 1, 2026
5:31 PM ET Form 4
Insider Selling Cardlytics, Inc. CDLX

Cardlytics CEO Amit Gupta Sells $46.7K of Stock

Amit Gupta, CEO, sold 17,733 shares of Cardlytics, Inc. at $2.53 to $2.71 a share (average $2.64) in 2 transactions, worth $46.7K in total between Oct 1, 2026 and Oct 2, 2026. Shares held after the trade: 138,906 (-5.0%).

Value
$46.7K
Shares
17,733
Average price
$2.64
Role
CEO
Holding change
-5.0%
Trade date
Oct 1, 2026 to Oct 2, 2026
5:21 PM ET Form 4
Insider Selling Nurix Therapeutics, Inc. NRIX

Nurix Therapeutics CLO Christine Ring Sells $134K of Stock

Christine Ring, CLO, sold 5,786 shares of Nurix Therapeutics, Inc. at $23.19 a share, worth $134K in total on Oct 2, 2026. Shares held after the trade: 9,110 (-38.8%).

Value
$134K
Shares
5,786
Price
$23.19
Role
CLO
Holding change
-38.8%
Trade date
Oct 2, 2026
5:20 PM ET Form 4
Insider Selling PTC Therapeutics, Inc. PTCT

PTC Therapeutics Director Glenn Steele Jr. Md. Phd. Sells $782K of Stock

Glenn Steele Jr. Md. Phd., Director, sold 12,000 shares of PTC Therapeutics, Inc. at $65.16 a share, worth $782K in total on Sep 30, 2026. Shares held after the trade: 22,500 (-34.8%).

Value
$782K
Shares
12,000
Price
$65.16
Role
Director
Holding change
-34.8%
Trade date
Sep 30, 2026
5:20 PM ET Form 4
Insider Selling Rocket Lab Corp RKLB

Rocket Lab CFO Adam C. Spice Sells $9.93M of Stock

Adam C. Spice, CFO, sold 140,157 shares of Rocket Lab Corp at $70.28 to $71.79 a share (average $70.82) in 3 transactions, worth $9.93M in total on Oct 1, 2026. Shares held after the trade: 1,155,967 (-1.3%).

Value
$9.93M
Shares
140,157
Average price
$70.82
Role
CFO
Holding change
-1.3%
Trade date
Oct 1, 2026
5:20 PM ET Form 4
Insider Selling Ceribell, Inc. CBLL

Ceribell CTO Raymond Woo Sells $119K of Stock

Raymond Woo, CTO, sold 4,887 shares of Ceribell, Inc. at $24.38 a share, worth $119K in total on Oct 1, 2026. Shares held after the trade: 203,118 (-2.3%).

Value
$119K
Shares
4,887
Price
$24.38
Role
CTO
Holding change
-2.3%
Trade date
Oct 1, 2026
5:19 PM ET Form 4
Insider Selling Oramed Pharmaceuticals Inc. ORMP

Oramed Pharmaceuticals CFO Avraham Gabay Sells $90.2K of Stock

Avraham Gabay, CFO, sold 20,000 shares of Oramed Pharmaceuticals Inc. at $4.51 a share, worth $90.2K in total on Oct 1, 2026. Shares held after the trade: 861,076 (-2.3%).

Value
$90.2K
Shares
20,000
Price
$4.51
Role
CFO
Holding change
-2.3%
Trade date
Oct 1, 2026
5:19 PM ET Form 4
Insider Selling Oramed Pharmaceuticals Inc. ORMP

Oramed Pharmaceuticals COO & Cbo Joshua Hexter Sells $135K of Stock

Joshua Hexter, COO & Cbo, sold 30,000 shares of Oramed Pharmaceuticals Inc. at $4.51 a share, worth $135K in total on Oct 1, 2026. Shares held after the trade: 1,328,130 (-2.2%).

Value
$135K
Shares
30,000
Price
$4.51
Role
COO & Cbo
Holding change
-2.2%
Trade date
Oct 1, 2026
5:16 PM ET Form 4
Insider Selling Verastem, Inc. VSTM

Verastem President and CEO Dan Paterson Sells $353K of Stock

Dan Paterson, President and CEO, sold 44,121 shares of Verastem, Inc. at $8.00 a share, worth $353K in total on Oct 1, 2026. Shares held after the trade: 652,712 (-6.3%).

Value
$353K
Shares
44,121
Price
$8.00
Role
President and CEO
Holding change
-6.3%
Trade date
Oct 1, 2026
5:15 PM ET Form 4
Insider Selling Verastem, Inc. VSTM

Verastem CFO Daniel Calkins Sells $20.5K of Stock

Daniel Calkins, CFO, sold 2,566 shares of Verastem, Inc. at $8.00 a share, worth $20.5K in total on Oct 1, 2026. Shares held after the trade: 123,781 (-2.0%).

Value
$20.5K
Shares
2,566
Price
$8.00
Role
CFO
Holding change
-2.0%
Trade date
Oct 1, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.